Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Settlment Reached in Bellwether Fosamax Lawsuit

Filed September 21st, 2012 Laurie

The estate of Shirley Boles has reached a confidential agreement with Merck & Co. Inc. concerning the amount of damages to be paid by the pharmaceutical manufacturer to the late claimant’s estate.

The Plaintiff’s estate had previously been awarded $8 million by a federal court jury in New York after Boles suffered jawbone death as a result of taking the osteoporosis drug Fosamax, but that award was later overturned.

Merck has faced thousands of bellwether trials filed by Plaintiffs who alleged they developed jawbone ailments after taking Fosamax. The U.S. Food and Drug Administration issued a safety announcement in 2010 informing the public that patients taking the drug had an increased risk of atypical thigh and femur fractures.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!